1.
Open Forum Infect Dis
; 9(7): ofac194, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35794944
RESUMO
An elderly man with refractory Mycobacterium abscessus lung disease previously developed anti-phage neutralizing antibodies while receiving intravenous phage therapy. Subsequent phage nebulization resulted in transient weight gain, decreased C-reactive protein, and reduced Mycobacterium burden. Weak sputum neutralization may have limited the outcomes, but phage resistance was not a contributing factor.